Associated Papers
Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry.
Cruz-Utrilla A et al.
International Journal of Molecular Sciences, 2022
36142358 (PubMed )
Supplement: ijms-23-10433-s001.zip › Table_S1.pdf
Potassium (K+) channels in the pulmonary vasculature: Implications in pulmonary hypertension Physiological, pathophysiological and pharmacological regulation.
Mondéjar-Parreño G et al.
Pharmacology & Therapeutics, 2021
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.
Le Ribeuz H et al.
Biomolecules, 2020
TASK channels: channelopathies, trafficking, and receptor-mediated inhibition.
Inoue M et al.
Pflugers Archiv : European Journal of Physiology, 2020
Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
Cunningham KP et al.
The Journal of Physiology, 2019
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.
Olschewski A et al.
The European Respiratory Journal, 2017
An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension.
Navas Tejedor P et al.
Clinical Genetics, 2017
Select a paper to view details